Physician

Yogesh K Gandhi, MD

According to 2025 Medicare claims, Yogesh Gandhi, MD (NPI: 1699744839) practices hematology in the Richmond, VA market, with the plurality of this provider's patient population coming from Petersburg City, VA. This provider's primary affiliated billing organization is VIRGINIA CANCER INSTITUTE INCORPORATED (NPI: 1730130980; TIN: 54-1066435) and primary practice location at 23805-0002.

Gandhi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 619 traditional Medicare patients, billed 54,052 HCPCS/CPT codes, and received $1,115,485 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 833 prescription claims across 160 beneficiaries totaling $2,278,783 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 23 claims. Open Payments data shows 50 records totaling $1,182. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $688,353 to $2,278,783. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	591	48,107	$740,821
2016	685	74,551	$988,092
2017	869	86,869	$1,129,165
2018	827	132,991	$1,314,518
2019	772	127,512	$1,496,493
2020	720	122,122	$1,597,349
2021	699	96,200	$1,173,306
2022	608	86,385	$1,217,321
2023	599	77,019	$1,307,458
2024	619	54,052	$1,115,485

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	94	474	$688,353
2016	96	571	$905,191
2017	99	626	$926,736
2018	92	564	$780,788
2019	103	567	$991,158
2020	96	559	$1,308,608
2021	123	633	$1,677,749
2022	127	777	$2,577,978
2023	137	789	$2,904,857
2024	160	833	$2,278,783

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	54	$1,331
2016	N/R	N/R	N/R
2017	N/R	35	$11,557
2018	N/R	N/R	N/R
2019	N/R	27	$4,872
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	23	$383
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	218	614	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	264	550	$64
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	80	200	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	186	293	$12
96372	Injection of drug or substance under skin or into muscle	86	296	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	62	1,715	$1,335,644
Lenalidomide	Lenalidomide	11	308	$215,684
Jakafi	Ruxolitinib Phosphate	14	420	$122,859
Eliquis	Apixaban	64	3,045	$57,349
Zarxio	Filgrastim-Sndz	11	231	$20,491

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$1,182	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yogesh K. Gandhi, MD?

Tedicare shows public-source Medicare data for Yogesh K. Gandhi, MD (NPI 1699744839), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yogesh K. Gandhi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yogesh K. Gandhi, MD?

Yogesh K. Gandhi, MD is linked to VIRGINIA CANCER INSTITUTE INCORPORATED (billing NPI 1730130980) in the available physician profile data.

Does Yogesh K. Gandhi, MD have Open Payments data?

Yogesh K. Gandhi, MD has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.